Two Sigma Advisers »

Galmed Pharmaceuticals shares owned by Two Sigma Advisers

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Two Sigma Advisers from 13F filings

Historical chart of Two Sigma Advisers investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Two Sigma Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Two Sigma Advisers

Quarter filed Position value Share count Share price at filing
2023-12-31 $20k 44k 0.46
2023-09-30 $31k 51k 0.62

More positions owned by Two Sigma Advisers

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Visa Com Cl A (V)
Merck & Co (MRK)
Micron Technology (MU)
Netflix (NFLX)
Paypal Holdings (PYPL)
Bristol Myers Squibb (BMY)
Qualcomm (QCOM)
Pinterest Cl A (PINS)
Meta Platforms Cl A (META)
General Motors Company (GM)

View all positions for Two Sigma Advisers

Top funds holding Galmed Pharmaceuticals

Walleye Trading Advisors
CVI Holdings
Two Sigma Advisers
Two Sigma Investments
Citadel Advisors
Wells Fargo & Company
TSFG
Advisor Group Holdings
Hanson McClain Advisors
Zrc Wealth Management
Bank of America Corporation

View all funds holding Galmed Pharmaceuticals